Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
ovarian cancer - search results
If you're not happy with the results, please do another search
Genomic instability and nuclear architecture in cancer
Sabine Mai and Aline Rangel-Pozzo, at the CancerCare Manitoba Research Institute and The University of Manitoba, Winnipeg, Canada, discuss genomic instability in relation to 3D spatial organisation of telomeres.
Cancer research: The only way to avoid a cancer epidemic
Dr Lynn Turner, Director of Research at Worldwide Cancer Research, states that cancer research is the only way to avoid a cancer epidemic.
How AI can help treat diseases such as cancer and stroke
Tim Wooller, Principal – Industrial Design, Sector Lead Healthcare, PDD, explores how AI can help treat diseases such as cancer and stroke.
A new generation of testing for cancer: tools for navigating data in clinical decision...
Utilising early cancer detection: Are we getting the most out of first order tests for symptomatic cancer patients?
Visualising genomic instability in cancer
Sabine Mai and Aline Rangel-Pozzo from CancerCare Manitoba Research Institute, The University of Manitoba, explore how 3D imaging and quantitative analysis provide key insights into genomic instability.
A new wave of molecular cancer therapeutics
Hernando Lopez-Bertoni, explores the new wave of molecular cancer therapeutics and states the case for learning the mechanisms as a pro, so one can target them as an artist.
Single cell cancer research
Chair of Medical Cell BioPhysics Leon WMM Terstappen highlights why the interrogation of the cancer cells at the single cell level is required to truly understand cancer development.
Drug gives 34% protection against lung cancer recurrence
The NHS have gained a new drug, atezolizumab, which can give 34% protection against lung cancer recurrence or death, post-chemotherapy.
Non-melanoma skin cancers & malignant melanoma
Prof Dangou from the WHO Regional Office for Africa, Congo, speaks about the different kinds of skin cancer:non-melanoma skin cancers and malignant melanoma.
Cancer treatment: Radiotherapy
Cancer Centre London’s Keisha Robinson spoke to Open Access Government about cancer treatment in the UK today, in particular, radiotherapy.
Suffering with Premature Ovarian Insufficiency (POI) in the workplace
Dr Ghazala Aziz-Scott, a specialist in Women’s health at The Marion Gluck Clinic, explores how Premature Ovarian Insufficiency (POI) can affect working women and how they can discuss this problem with their employer.
Swansea University Medical School’s Director of Research releases 100th cancer research paper
After a career spanning more than 20 years, a Swansea University Professor’s passion for research is as ‘strong as ever’, as he marks a very notable achievement – the release of his 100th cancer research paper.
Redefining efficiency based on what matters to cancer patients
Redefining efficiency based on what matters to cancer patients is placed under the spotlight here by All.Can, including identifying opportunities for change.
The advancement of cancer research for the public benefit
European Association for Cancer Research’s Chief Executive Officer, Jane Smith, explains why the advancement of cancer research is purely for the public benefit, as well as the importance of collaboration in the field.
Artificial Intelligence to improve cancer diagnosis
Ambitious new plans set out by the Prime Minister today will see around 22,000 fewer people dying from cancer each year by 2033
Early stage diagnosis – spotting early stage cancer events
Cecilia Van Cauwenberghe, Vandana Iyer and Bhargav Rajan from Frost & Sullivan examine of how nanotechnology helps spot early stage cancer
Targeted drugs: Improving the lives of cancer patients
On Target Laboratories' Dr Sumith A. Kularatne shares his research into targeted drugs and notes the difference this treatment makes to cancer patients
How far have we come on treating gynaecological cancer?
New avenues are opening up for treatment of gynaecological cancer, Professor Gunnar Kristensen of Oslo University Hospital explains to Open Access Government
Surgery remains an important step in the treatment of ovarian cancer. Two earlier randomised studies revealed the same survival rates for patients who had surgery as the first...
Drug development for cancer and inflammatory disease
Sumith A Kularatne, Vice President of Research and Development at On Target Laboratories shares the research strides he has made in drug development
Changes to Cancer Drugs Fund is “deeply concerning”
Charities have warned changes to the Cancer Drugs Fund are concerning and could leave many new drugs struggling to gain approval…
Fifteen cancer charities have written to the Prime Minister expressing their concerns over changes to how innovative cancer drugs are approved for the NHS.
The letter outlined fears that many...
